SHARPE·IQStart free
Menu
TodayResearchEarningsToolsPricingSign in
HELE reported Q2 Fiscal 2027 (three months ended August 31, 2026) results. The price and volatility reaction is pending.
HELEearnings

Helen of Troy Limited (HELE) Q2 FY2027 earnings

October 8, 2026 · SharpeIQ Research Desk

Reported results

  • Consolidated net sales revenue of $440.9 million compared to $431.8 million in Q2 FY2026, an increase of 2.1%
  • GAAP diluted earnings per share of $0.19 compared to diluted loss per share of $13.44 in Q2 FY2026
  • Non-GAAP adjusted diluted EPS of $0.79 compared to $0.59 in Q2 FY2026, an increase of 33.9%
  • Gross profit margin of 52.2% compared to 44.2% in Q2 FY2026
  • Non-GAAP adjusted EBITDA of $49.4 million compared to $36.2 million in Q2 FY2026, with adjusted EBITDA margin of 11.2% compared to 8.4%
  • Net cash provided by operating activities of $57.1 million compared to net cash used by operating activities of $10.5 million in Q2 FY2026

Guidance

  • Fiscal 2027 consolidated net sales guidance of $1.768 billion to $1.822 billion, representing (1.0)% to 2.0% growth
  • Fiscal 2027 GAAP diluted EPS guidance of $3.63 to $4.26, raised from prior guidance of $3.57 to $4.18
  • Fiscal 2027 non-GAAP adjusted diluted EPS guidance of $3.60 to $4.15, raised from prior guidance of $3.25 to $3.75
  • Fiscal 2027 GAAP net income guidance of $88 million to $103 million, raised from prior guidance of $85 million to $100 million
  • Fiscal 2027 non-GAAP adjusted EBITDA guidance of $203 million to $210 million, raised from prior guidance of $190 million to $197 million
  • Fiscal 2027 operating cash flow guidance of $163 million to $179 million, raised from prior guidance of $119 million to $130 million
  • Fiscal 2027 non-GAAP free cash flow guidance of $120 million to $140 million, raised from prior guidance of $85 million to $100 million

Notes

Q2 FY2027 results included gross pre-tax tariff refunds of $26.9 million, of which approximately $23 million was reinvested in the quarter, resulting in a net pre-tax benefit of approximately $4.0 million and a diluted EPS benefit of approximately $0.12. Beginning Q2 FY2027, the company adjusted divestiture litigation costs related to a 2021 divestiture in its non-GAAP measures. Prior year Q2 FY2026 included non-cash asset impairment charges of $326.4 million.

Price and volatility reaction

Source

The figures above come from the earnings release the company filed with the SEC on 2026-10-08 (8-K, Item 2.02). Read the original filing on sec.gov.

See this live in SharpeIQ

IV rank, historical IV and the single-ticker tools. The scanner and AI research are paid plans.

Open IV Rank →